ABI
JAZZ icon

Adamant Biomedical Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Adamant Biomedical Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$3.27M Hold
20,000
– – 0.78% 47
2014
Q3 		$3.21M Buy
+20,000
New +$3.07M 0.8% 45

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adamant Biomedical Investments's JAZZ Position: Q4 2014 in Review

Adamant Biomedical Investments held its Jazz Pharmaceuticals (JAZZ) position steady in Q4 2014 at 20,000 shares worth $3.27M. The position accounts for 0.78% of the portfolio, ranked #47.

Adamant Biomedical Investments first reported a position in JAZZ in Q3 2014 and has held it in 2 quarters since. 357 funds tracked by Wall St. Rank hold JAZZ as of Q4 2014.

  • Adamant Biomedical Investments held 20,000 shares of Jazz Pharmaceuticals worth $3.27M as of Q4 2014.
  • Adamant Biomedical Investments left its Jazz Pharmaceuticals share count unchanged in Q4 2014.
  • Jazz Pharmaceuticals made up 0.78% of Adamant Biomedical Investments's portfolio in Q4 2014, its #47 holding.
  • Adamant Biomedical Investments first reported a position in Jazz Pharmaceuticals in Q3 2014 and has held it in 2 quarters since.
  • 357 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.